Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

NCT00711204 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No patients were enrolled in the study.

Conditions

Severe Alzheimer's Disease

Interventions

DRUG: Donepezil Hydrochloride (Aricept)

Sponsor

Eisai Inc.

Collaborators

[object Object]